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Abstract
Background: Previously we have reported that patients with rheumatoid arthritis (RA) obtained
a significant reduction in disease activity by adopting a Mediterranean-type diet. The present study
was carried out to investigate the antioxidant intake, the plasma levels of antioxidants and a marker
of oxidative stress (malondialdehyde) during the study presented earlier.
Methods: RA patients randomized to either a Mediterranean type diet (MD group; n = 26) or a
control diet (CD group; n = 25) were compared during a three month dietary intervention study.
Their antioxidant intake was assessed by means of diet history interviews and their intake of
antioxidant-rich foods by a self-administered questionnaire. The plasma levels of retinol,
antioxidants (α- and γ-tocopherol, β-carotene, lycopene, vitamin C and uric acid) and urinary
malondialdehyde (MDA), a marker for oxidative stress, were determined using high performance
liquid chromatography. The Student's t-test for independent samples and paired samples were used
to test differences between and within groups. For variables with skewed distributions Mann-
Whitney U-test and Wilcoxon signed ranks test were performed. To evaluate associations
between dietary intake of antioxidants, as well as between disease activity, MDA and antioxidants
we used Pearson's product moment correlation or Spearman's rank correlation.
Results: The MD group had significantly higher intake frequencies of antioxidant-rich foods, and
also higher intakes of vitamin C (p = 0.014), vitamin E (p = 0.007) and selenium (p = 0.004), and a
lower intake of retinol (p = 0.049), compared to the CD group. However, the difference between
the groups regarding vitamin C intake was not significant when under- and over-repoters were
excluded (p = 0.066). There were no changes in urine MDA or in the plasma levels of antioxidants
(after p-lipid adjustments of the tocopherol results), from baseline to the end of the study. The
levels of retinol, vitamin C and uric acid were negatively correlated to disease activity variables. No
correlation was found between antioxidant intake and the plasma levels of antioxidants.
Conclusions: Despite an increase in reported consumption of antioxidant-rich foods during the
Mediterranean diet intervention, the levels of plasma antioxidants and urine MDA did not change.
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However, the plasma levels of vitamin C, retinol and uric acid were inversely correlated to variables
related to RA disease activity.
Background
In a recent study we have shown that patients with rheu-
matoid arthritis (RA) that adopted a Cretan Mediterra-
nean diet obtained a reduction in inflammatory activity,
an increase in physical function and in vitality, whereas
no significant changes were seen in the control group,
who followed their habitual diet [1].
For a long time the beneficial effects of the Mediterranean
diet have primarily been attributed to its lipid profile.
However, recently attention has been drawn to the anti-
oxidants [2–5]. Vegetables, fruit and olive oil have a cen-
tral position in the Mediterranean diet and these food
items contain a variety of compounds with an antioxidant
capacity, such as vitamin C and E, carotenoids and
polyphenols [2].
There is evidence indicating that a low antioxidant status
is associated with a higher risk of developing RA [6–8].
Furthermore, the rheumatoid inflammation is associated
with an increased generation of oxidants (reactive oxygen
and nitrogen species), which play an important role in the
inflammatory process and contribute to tissue destruction
[9]. Antioxidant defences limit the damages caused by oxi-
dants, such as those formed during inflammation. In
addition, in vitro-studies and animal studies have shown
that antioxidants also possess anti-inflammatory proper-
ties [10–13]. This implies that antioxidative defence
mechanisms are of particular importance for patients with
RA and that the effects of antioxidative nutrients ought to
be further investigated.
Most controlled studies investigating the therapeutic use
of antioxidant supplementation have not shown any sig-
nificant effects on RA symptoms (reviewed in [14]). In
contrast to these studies, in a placebo-controlled trial,
vitamin E was reported to have a mild, but significant,
analgesic effect [15]. Since many of the antioxidant com-
pounds interact in the body, supplementation with indi-
vidual antioxidants may not be the best way to strengthen
the antioxidant defence. In a small study by Helmy et al
[16] supplementation with a combination of antioxi-
dants, in addition to standard treatment, gave better
results regarding clinical indices of RA compared to stand-
ard treatment alone. This indicates that supplementation
with a combination of antioxidants, or a diet providing a
cocktail of different antioxidants, may be more effective
than supplementation with single nutrients. Therefore,
the beneficial effect of the Cretan Mediterranean diet,
which we recently tested on patients with RA [1] could, at
least in part, be attributable to the high content of antioxi-
dants in this diet. Since this needs to be investigated fur-
ther, the aims of the present study were to examine our
patients with respect to their antioxidant intake, their
plasma level of antioxidants, and by means of a marker of
oxidative stress (malondialdehyde).
Methods
Patients and study design
The study has been approved by the local ethical commit-
tee and the ethical principles of the Helsinki Declaration
were followed.
56 patients with RA according to the 1987 ACR criteria
[17] were included in the study. The patients were
enrolled in groups of two to six persons, with new groups
starting every third week from September 1998 to Novem-
ber 2000. After baseline measurements they were rand-
omized to either a modified Cretan Mediterranean Diet
(MD) group or a Control Diet (CD) group. The randomi-
zation was done by means of block randomization, strat-
ified for sex. 26 MD subjects (21 women and 5 men, mean
age 58 years) and 25 CD subjects (20 women and 5 men,
mean age 59 years) completed the study. At baseline the
MD group had a significantly higher Body Mass Index
(BMI) and a longer disease duration compared to the CD
group (p = 0.024 and 0.047, respectively). Apart from this
no differences were seen between the groups at the start of
the study (for details see reference 1).
All the patients had well controlled, although active, RA
(Disease Activity Score from 28 joints >2.0) and a disease
duration of at least 2 years. The pharmacological treat-
ment had to have been kept stable prior to inclusion, i.e.
the Disease Modifying Anti-Rheumatic Drugs (DMARD)
had to be unchanged for ≥ 3 months, the corticosteroids
for  ≥ 4 weeks, and Non-Steroidal Anti-Inflammatory
Drugs (NSAID) for ≥10 days. Furthermore, the daily dose
of oral corticosteroids was not to exceed 12.5 mg/day of
Prednisolone. Patients who had other conditions that
demanded active medical attention were not included in
the trial. Vegetarians and patients already eating a Medi-
terranean-like diet were excluded. Throughout the experi-
mental period the doses of DMARD and corticosteroids
were kept constant. The individual dose of NSAID could
be adjusted, but the doses had to be documented in the
study protocol. Four violations to the protocol in the form
of intra-articular injections with triamcinolone hexaceto-
nide were reported. The injections were given to one MDNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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patient and three CD patients (for details see reference 1).
None of these patients were excluded.
If the subjects of the study used any dietary supplementa-
tion (e.g. fish oils, vitamins, minerals, etc.) prior to the
study this was recorded. All such supplementation had to
be kept unchanged during the study. During the first three
weeks both groups took part in an outpatient rehabilita-
tion program at the Kalmar Hospital Rheumatology Unit.
This program runs from 9 a.m. to 5 p.m., Monday to Fri-
day, and consists of patient education, strength and fit-
ness training, along with individual physio- and
occupational therapy. During these weeks (Monday to Fri-
day) all the patients were served lunch and dinner (Cretan
diet or the ordinary hospital food, according to the rand-
omization) which were planned by the first author (LH)
and managed by the hospital food service establishment.
For the following nine weeks the MD group continued to
eat the Mediterranean diet, while the CD group ate their
normal diet, now preparing all meals themselves.
Diets
The Cretan Mediterranean diet has previously been tested
by de Lorgeril et al, in a secondary prevention trial of cor-
onary heart disease [18]. In the present study we based the
experimental diet on the diet used in that study, but with
some modifications in order to suit Swedish food habits.
In brief, the instructions to our MD group were to eat a
large amount of fruits, vegetables, pulses, cereals, fish
(particularly fish with a high content of ω-3 fatty acids)
and nuts and seeds with a high content of α-linolenic
acid. The intake of meat (such as pork, beef, lamb or mut-
ton), cured meat, sausage etc. were to be replaced by poul-
try, fish or vegetarian dishes. Both olive oil and canola oil
were used for food preparations, baking and in salad
dressings. The MD group were also advised to use two
types of margarines based on canola oil: a liquid marga-
rine (80% fat) for cooking and a half-fat margarine (40%
fat) to use on bread. Furthermore, the MD group were
advised to replace high fat dairy products with low fat
products. The traditional Mediterranean diet is generally
characterised by a moderate and regular alcohol con-
sumption, especially in the form of red wine. However, in
the present study no recommendations were given regard-
ing alcohol consumption. To compensate for the antioxi-
dants in wine, we advised the MD group to drink green or
black tea.
To promote good compliance to the Mediterranean diet
some food items were supplied free to the MD group,
namely: frozen vegetables, tea, olive oil, canola oil and the
liquid and half-fat margarines based on canola oil.
During the three-week ORP, the MD group had six lessons
from a dietician about Mediterranean food and cooking.
They were also given written instructions and recipes to
facilitate the preparation of meals at home. After the ORP
the dietician was available weekly for telephone consulta-
tion, and every third week the MD group had the oppor-
tunity to meet the dietician and the other MD subjects.
Dietary assessments
At baseline and at week three and twelve, patients of both
groups completed a self-administrated questionnaire. The
questionnaire was specifically designed to investigate
compliance with the Mediterranean diet and included 86
questions (both open and closed questions) mainly con-
cerning food choices, food intolerance and dietary supple-
mentation. Some questions were about food frequencies,
where the subjects should state their average intake of var-
ious food items by marking one of six alternatives ranging
from "rarely or never" to "two or more times per day". To
be able to compare the consumption between the two
groups, as well as consumption at different points in time,
the food frequencies were converted to average consump-
tion per month. For example, if a consumption of 3–5
times per week was marked this would be converted to 16
times per month.
To obtain more detailed data on the energy and nutrient
intake, diet history interviews were conducted with 34
patients from both the experimental group and the con-
trol group (15 women and 2 men from each group). The
only selection criterion for taking part in the diet history
interviews was that the subjects were included in the study
on February the 15th 1999, or later. One purpose of the
diet history interviews was to study the compliance with
the experimental and control diets when the patients were
preparing their meals at home. Therefore, all the inter-
views were performed between study weeks seven and
twelve. It covered the intake during the past month but
never included the ORP. The interview started with ques-
tions about the subject's meal patterns on weekdays and
weekends. Subsequently each meal and between-meal
snack was discussed in detail, with questions about food
choices, frequencies and portion sizes. To estimate the
average portion sizes, household measurements, vali-
dated food portion photographs [19], bags of rice of dif-
ferent sizes or standard weights of food items [20] were
used. Most of the interviews were performed by the first
author (LH) but two other specially trained dieticians
interviewed five patients each. The interviews were either
conducted in the subject's home or at the rheumatology
unit, Kalmar Hospital.
The estimated intake of energy and nutrients, assessed by
the diet history method, were calculated using the nutri-
tional analysis package MATs 4_03e. This program isNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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based on the Swedish National Food Administration's
food composition database, PC-kost (version 2_97). For
composite food items and supplements not listed in the
database the nutrient content was entered manually.
When uncooked foods were used in cooked dishes the
amount of ascorbic acid was adjusted by the program, i.e.
the ascorbic acid was decreased to 50% of the original
value.
The energy and nutrient intake was calculated both
including and excluding dietary supplements.
Validation of the diet history interviews
To obtain a crude estimate of the validity of the diet his-
tory interviews, we compared the reported energy intake
with the energy expenditure of the subjects. The energy
expenditure was estimated using a three-day activity regis-
tration method, previously used in the SOS (Swedish
Obese Subjects) study [21]. If a person is in energy bal-
ance the habitual energy intake (EI) should equal the
energy expenditure (EE). In the present study, subjects
with a ratio EI:EE between 0.79 and 1.21 were regarded as
valid reporters, those with a ratio less than 0.79 were
regarded as under-reporters and those with a ratio greater
than 1.21 as over-reporters [22].
The diet history interviews were also validated by compar-
ing the reported energy intake with the energy expenditure
determined by the doubly labelled water method (per-
formed for 9 subjects), and the excretion of nitrogen,
sodium and potassium in 24-h urine samples, were used
to validate the reported intake of protein, sodium and
potassium. The results of the validation with biological
markers will be presented elsewhere.
Assessment of plasma antioxidants and urine 
malondialdehyde
Blood and urine collection
Blood samples were drawn into heparinazed vacutainer
tubes between 8.00 and 9.00 a.m., after an overnight fast.
When the blood had reached room temperature the sam-
ples were centrifuged at 2,000 rpm for 10 minutes and
aliquots of plasma were transferred to 1.5 ml Eppendorf
tubes and stored at -70°C before being analyzed. For anal-
ysis of vitamin C, 500 µl plasma was immediately trans-
ferred to Eppendorf tubes and mixed with an equal
volume of 10% m-phosphoric acid before the samples
were frozen.
After receiving instructions, each participant collected a
morning urine sample (15 ml) on the day of the visit to
the hospital. On arrival the urine samples were frozen at -
20°C.
Chemicals
1,1,3,3-tetraethoxypropane (97%), β-carotene (95%), lyc-
opene (95%), vitamin A, α-tocopherol, γ-tocopherol, L-
ascorbic acid (>99%), uric acid (>99%) and butylated
hydroxytoluene (BHT) were all from Sigma Chemical
Company St. Louis IN, USA. The thiobarbituric acid
(99%) was from Merck KGaA, Darmastadt, Germany.
The standard reference material 968 b (for carotenoids
and tocopherols) was obtained from the National Insti-
tute of Standards and Technology, Gaithersburg, MD,
USA.
Biochemical analysis
Malondialdehyde
The urine was thawed, vortexed and centrifuged at 2,000
rpm for 5 minutes. After determining the specific density,
aliquots of 50 µl urine were mixed with 300 µl o-phos-
phorus acid (0.5 mol/L) and 150 µl thiobarbituric acid
(23 mmol/L) in 1.5 ml Eppendorf tubes. After this, the
samples were incubated for 55 minutes at 95°C and then
chilled on ice before they were centrifuged for 3 minutes
at 14,000 g. Malondialdehyde (MDA) was then deter-
mined using HPLC (high performance liquid chromatog-
raphy) and 20 µl of each sample was injected and
separated on a Chromolite Performance column (100 ×
4.6 mm, RP-18e, Merck KGaA, Darmastadt, Germany).
The mobile phase consisted of 70% 50 mmol/L potas-
sium phosphate (pH 6.8) and 30 % methanol and the
flow rate was 3 ml/min. The malondialdehyde – thiobar-
bituric acid complex was detected with a fluorescence
detector (Merck-Hitatchi F 1000 Fluorescence Spectro-
photometer) with excitation and emission wavelengths of
525 and 550 nm, respectively. The density-corrected
malondialdehyde concentrations (adjusted MDA) were
calculated by using the following formula: Density cor-
rected value = concentration in urine × ((1.024 -1) / (con-
centration in urine -1)). Standard curves of
malondialdehyde were prepared from 1,1,3,3-tetraethox-
ypropane (1 – 5 µmol/L) mixed with o-phosphorous acid
and thiobarbituric acid and treated in the same way as the
samples.
Vitamin A and fat and water soluble antioxidants
Vitamin A, α- and γ-tocopherol and carotenoids, was
determined using HPLC according to a method that has
been described previously by Hess et al [23]. The quantifi-
cation of the single compounds was performed by an
external standard method based on peak area. The con-
centrations of the different samples were also checked and
compared with the standard reference materials 968 b
from the National Institute of Standards and Technology,
USA (carotenoids and vitamin E) and INSTAND e.V. Düs-
seldorf, Germany (vitamin A and E).Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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Analyses of vitamin C and uric acid were also performed
using HPLC. The samples (diluted 1:1 with 10% m-phos-
phorous acid) were thawed at 4°C and centrifuged at
14,000 g for 2 minutes and 20 µl aliquots of the clear
supernatants were injected in the chromatograph. Both
vitamin C and uric acid were determined with a spectro-
photometric detector at the wavelength 262 nm. The
HPLC pump was a 880-PU and the detector a 875-UV,
both from Jasco (Japan Spectroscopic Company Ltd.,
Tokyo, Japan) and the injector was a Rheodyne 7125 from
Rheodyne Inc., Cotati, CA, USA. The analytical column
was a Chromolite Performance column (100 × 4.6 mm,
RP-18e, Merck KGaA, Darmastadt, Germany). The mobile
phase consisted of 200 mmol/L KH2PO4, pH 3.0 and the
flow rate was 2.5 ml/minute. Standard curves with a con-
centration of 0–100 µmol/L (vitamin C) and 0 – 300
µmol/L (uric acid) were prepared and used for the quanti-
fication. Stock solutions with a concentration of 10
mmol/L were first prepared in water (vitamin C) or 0.05
mol/L NaOH (uric acid) and then diluted further with 5%
m-phosphorus acid.
Clinical and laboratory assessments
Clinical and laboratory evaluations were performed at
baseline and in week three, six and twelve, and comprised
Disease Activity Score from 28 joints (DAS28; a clinical
assessment of disease activity), the Health Assessment
Questionnaire (HAQ; a self-administered questionnaire
Table 1: Comparison of reported food consumption frequencies (servings per month) between the Mediterranean Diet (MD) group and 
the Control Diet (CD) group. The food consumption frequencies are based on the food frequency questionnaires. The data are 
presented as medians (25th-75th percentiles).
MD group (n = 26) CD group (n = 25) p-value*
Time (weeks after dietary shift) Time (weeks after start of study)
03 1 2 03 1 2
Cooked root 
vegetables
6(2–16) 16(6–16) 11(5–16) 2(2–6) 6(0–6) 2(0–6) 0.027
Raw root 
vegetables
6(2–16) 16(16–26) 6(6–16)† 6(1–16) 6(2–6) 6(2–16) 0.013
Cooked green 
vegetables
16(6–16) 16(16–26) 26(16–26)‡ 6(4–16) 6(4–16) 6(2–16) <0.001
Raw green 
vegetables
16(6–19) 26(24–37) 21(16–26)‡ 16(6–26) 16(6–26) 6(4–21) 0.001
Legumes 2(0–6) 11(5–16) 6(2–16)§ 2(0–4) 2(2–6) 2(0–2) 0.002
Fruit and berries 16(6–26) 16(14–26) 16(6–26) 16(4–48) 16(2–26) 6(2–21)† 0.395
Fish 6(6–6) 16(6–16) 16(16–16)§ 6(2–6) 6(6–16) 6(2–6) <0.001
Shellfish 2(0–2) 2(0–6) 4(2–6)‡ 2(0–2) 2(0–2) 2(0–2) <0.001
Black tea 7(0–16) 7(0–42) 7(0–42) 7(0–42) 7(0–42) 7(0–42) 0.015
Green tea 0 25(0–42) 7(0–42)§ 0 0 0 <0.001
*The p-values refer to differences between the MD and CD groups concerning the change from baseline to week 12. Differences between the 
groups were analysed by Mann-Whitney U test. Statistically significant change from baseline to week 12: † p < 0.05, ‡ p < 0.01, § p < 0.001. Within- 
group differences at week 12 compared to baseline were evaluated by Wilcoxon signed ranks test.
Table 2: Comparison of reported dietary intake (excluding supplements) between the Mediterranean Diet (MD) group and the Control 
Diet (CD) group. The reported dietary intake is based on the diet histories performed between study weeks seven and twelve. The data 
are presented as mean values ± SD.
MD group (n = 17) CD group (n = 17) p-value*
Vitamin A (RE†) 1560 ± 770 1760 ± 930 0.500
Retinol (µg) 672 ± 325 1115 ± 760 0.049
β-carotene (µg) 5000 ± 4190 3550 ± 2620 0.339
Vitamin E (α-TE‡) 13 ± 4 9 ± 4 0.007
α-tocopherol (mg) 12 ± 3 9 ± 3 0.007
Vitamin C (mg) 157 ± 78 106 ± 76 0.014
Selenium (µg) 56 ± 17 39 ± 15 0.004
*P-values refer to the difference between the MD and CD groups. Differences between groups were analysed by the Students t-test for 
independent samples, except for retinol, β-carotene and vitamin C which were evaluated by the Mann-Whitney U test. †retinol equivalents. ‡α-
tocopherol equivalentsNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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used to assess functional capacity for activities of daily liv-
ing), the Westergren Erythrocyte Sedimentation Rate
(ESR), and the C-reactive protein (CRP) and thrombocyte
count.
Statistical methods
The Student's t-test for independent samples was used to
test differences between groups regarding plasma levels of
antioxidants, urine MDA and nutrient intake. For these
variables within-group differences from baseline to week
12 were evaluated using Student's t-test for paired sam-
ples. For variables with skewed distributions (plasma β-
carotene and intakes (including supplements) of retinol,
β-carotene,  α-tocopherol, total vitamin E and ascorbic
acid, as well as retinol, β-carotene and vitamin C intake
when supplements were excluded), and for reported con-
sumption of food items, the Mann-Whitney U-test was
performed to test differences between the groups. For
these variables the Wilcoxon signed ranks test was used to
analyze differences within groups, from baseline to week
12.
To evaluate the association between dietary intake and the
plasma levels of antioxidants, as well as between disease
activity, MDA and plasma antioxidants, we used Pearson's
product moment correlation. However, Spearman's rank
correlation was used for variables with skewed distribu-
tions (plasma β-carotene, CRP and intakes of β-carotene,
α-tocopherol, total vitamin E and ascorbic acid, when
supplements were included).
When associations between plasma antioxidants and var-
iables related to disease activity were evaluated, we used
the baseline levels of all the study subjects. When relations
between dietary intake of antioxidants and plasma levels
of antioxidants were evaluated, we used the reported
nutrient intake obtained from the diet history interviews
and the mean plasma levels of antioxidants taken in the
same time period, i.e. between weeks 6 and 12.
The statistical analyses were performed using SPSS for
Windows, version 11.0.1. A P value of <0.05 was consid-
ered statistically significant.
Results
Dietary intake
At baseline there were no significant differences between
the groups regarding consumption frequencies of food
items rich in antioxidants (table 1).
The main increases in several antioxidant-rich food items
were seen during the ORP (week three), when lunch and
dinner were served at the Rheumatology unit (table 1). At
the end of the study, the intake frequencies of both raw
and cooked vegetables, legumes, fish, shellfish and green
tea, had increased in the MD group. In the control group
there was a significant decrease in the reported intake fre-
quency of fruit and berries. When comparing the two
groups the changes in food consumption frequencies of
almost all the food items studied, were significantly
greater in the MD group.
The nutrient intake during the second half of the study
was estimated by means of the diet history interviews.
Since the results at the group level were unchanged,
whether we excluded under- and over-reporters or not
(with the exception that there was no significant differ-
ence between the groups regarding vitamin C intake,
when under- and over-reporters were excluded, p =
0.066), the results of all the diet history interviews are pre-
sented (table 2). When comparing the nutrient intakes
(excluding supplements), the MD group had a lower
reported intake of retinol and a higher intakes of vitamin
C, α-tocopherol, total vitamin E and selenium, compared
to the CD group.
When supplements were included in the nutrient intake,
there was no difference between groups regarding intake
of retinol (p = 0.099). The intakes of vitamin C, α-toco-
pherol, total vitamin E, and selenium was still higher in
the MD group with this approach (p = 0.034, p = 0.003, p
= 0.004 and p = 0.021 respectively).
In comparison with the Average Requirement (AR),
according to the Nordic Nutrition Recommendations
(NNR) [24], the intake (excluding supplements) of all the
MD subjects exceeded the AR for vitamins A and C and
selenium. No AR for vitamin E has been stated in the
NNR, but in the MD group the vitamin E intake of all the
subjects exceeded the recommended intake (NNR)
[24,25]. In the CD group, our data indicates that a
number of patients did not reach the AR, namely one in
the case of vitamin A, one regarding vitamin C and six
regarding selenium. Eight CD subjects did not reach the
recommended intake of vitamin E. Of these eight subjects
one had an intake of vitamin E that was below the lower
limit of intake according to the NNR. However, when
under-reporters (two CD subjects) were excluded, all the
CD subjects reached the AR for vitamins A and C. Only six
control subjects had a vitamin E intake below the recom-
mended intake (and none under the lower limit of intake)
and four CD subjects still had a selenium intake below the
AR. The number of subjects that exceeded the AR and rec-
ommended intake did not change when we included the
dietary supplements in the nutrient intake.
Levels of plasma antioxidants and urine malondialdehyde
No differences were seen between the groups regarding
plasma levels of antioxidants or the marker of oxidative
stress, MDA in urine, at the start of the study (table 3).Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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At the end of the study α-tocopherol and γ-tocopherol
were significantly below the baseline levels in the MD
group. When tocopherols were expressed in relation to
plasma lipids, by dividing α- and γ-tocopherol respec-
tively with p-cholesterol plus p-triglycerides, the change
from baseline to week 12 did not reach statistical signifi-
cance regarding α-tocopherol (p = 0.076). However, the
baseline level of α-tocopherol was correlated to the
plasma concentrations of both cholesterol (r = 0.402, p <
0.01) and triglycerides (r = 0.591, p < 0.01), whereas the
level of γ-tocopherol correlated only to plasma triglycer-
ides (r = 0.381, p < 0.01). Therefore we also calculated the
γ-tocopherol:triglycerides ratio, and when γ-tocopherol
was expressed in relation to p-triglycerides the changes
from baseline did not reach statistical significance (p =
0.133).
When the dietary intake (including supplements) of nutri-
ents (retinol, β-carotene, α-tocopherol and ascorbic acid)
was related to the plasma levels of the corresponding
nutrients, no significant correlation was found. However,
the plasma levels of some nutrients were associated with
variables related to disease activity. Statistically significant
inverse correlation was observed between retinol and ESR
(r = -0.38, p < 0.01), DAS28 (r = -0.31, p < 0.05) and CRP
(r = -0.48, p < 0.01) respectively. A negative relationship
was also found between vitamin C and ESR (r = -0.33, p <
0.05) as well as between vitamin C and the HAQ score (r
=-0.34, p < 0.05). Furthermore, uric acid was negatively
correlated with the thrombocyte count (r = -0.28, p <
0.05).
The concentration of MDA in urine did not change statis-
tically in any of the groups during the study period. No
correlation was found between MDA and the indices of
disease activity. However, at baseline the concentrations
of MDA in urine as well as the adjusted MDA, were
inversely related to the plasma concentration of γ-toco-
pherol (r = -0.30, p < 0.05 and r = -0.36, p < 0.05
respectively).
Discussion
Dietary Antioxidants
In the present study we investigated the plasma levels and
nutrient intake of antioxidants that are abundant in the
traditional Mediterranean diet, i.e. carotenoids, vitamin
C, vitamin E and selenium [2]. After the intervention the
consumption of several antioxidant-rich foods increased
in the MD group, and as expected this group had a higher
intake of most antioxidants compared to the CD group.
More surprising were the results for plasma antioxidants.
Although the consumption of antioxidant-rich foods
increased, the concentrations of plasma antioxidants were
relatively constant throughout the study period. From
baseline to the end of the study the plasma levels of α-
tocopherol and γ-tocopherol even decreased to signifi-
cantly lower concentrations in the MD group. Since toco-
pherols circulate in the blood with the lipoproteins, the
Table 3: Comparison of plasma levels of retinol (mmol/l), antioxidants (mmol/l) and urine malondialdehyde (mmol/l) between the 
Mediterranean Diet (MD) group and the Control Diet (CD) group. The data are presented as mean values ± SD.
MD group (n = 26)* CD group (n = 25)†
Time (weeks after dietary shift) Time (weeks after start of study)
03 1 2 03 1 2
Retinol 2.32 ± 1.07 2.21 ± 0.70 2.12 ± 0.63 2.17 ± 1.15 2.23 ± 0.98 2.01 ± 0.62
β-carotene 0.56 ± 1.20 0.72 ± 1.03 0.49 ± 0.85 0.31 ± 0.21 0.43 ± 0.28 0.36 ± 0.25
Lycopene 0.35 ± 0.23 0.39 ± 0.25 0.40 ± 0.26 0.27 ± 1.17 0.30 ± 0.18 0.26 ± 0.15
Vitamin C 51 ± 16 62 ± 16 51 ± 20 54 ± 22 62 ± 20 52 ± 28
α-tocopherol 36 ± 11 33 ± 8 30 ± 9|| 34 ± 7 32 ± 8 31 ± 9
α-tocopherol:(C+TG) ratio‡ 4.94 ± 1.13 5.27 ± 1.22 4.51 ± 1.27 5.12 ± 1.07 4.93 ± 1.23 4.85 ± 1.27
γ-tocopherol 2.42 ± 1.15 2.26 ± 0.96 1.85 ± 0.83¶ 2.46 ± 1.13 1.96 ± 0.63 2.06 ± 0.80
γ-tocopherol:(C+TG) ratio‡ 0.32 ± 0.15 0.34 ± 0.14 0.26 ± 0.11** 0.37 ± 0.16 0.31 ± 0.13 0.32 ± 0.12
Uric acid 293 ± 68 304 ± 75 297 ± 83 262 ± 59 261 ± 57 265 ± 73
Malondialdehyde 1.23 ± 0.52 1.21 ± 0.30 1.07 ± 0.34 1.21 ± 0.58 1.36 ± 0.58 1.24 ± 0.66
Malondialdehyde adj.§ 2.18 ± 0.75 2.51 ± 0.64 2.22 ± 0.46 2.09 ± 0.46 2.08 ± 0.54 2.15 ± 0.78
*Complete data on plasma concentrations of vitamin C and uric acid were only available for 25 diet group subjects. Complete data on plasma α-
tocopherol were available for 24 diet group subjects. †Complete data on plasma concentrations of lycopene were only available for 22 control 
group subjects. Complete data regarding the other antioxidants were available for 23 control subjects. ‡C = plasma total cholesterol, TG = plasma 
triglycerides, i.e. tocopherol:(cholesterol+triglycerides), mmol/l:mmol/l. §Malondialdehyde adjusted for density. Statistically significant change from 
baseline to week 12: || p = 0.006, ¶ p<0.017, ** p = 0.026. Within-group differences at week 12 compared to baseline were evaluated by the 
Student's t-test for paired-samples, except for β-carotene which was analysed by the Wilcoxon signed ranks test.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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plasma levels are often influenced by the blood lipid con-
centration. During the course of this study, the total cho-
lesterol decreased significantly in the MD group (results
presented elsewhere) [1] and it is possible that this change
caused the decreased levels of plasma tocopherols as well.
For this reason we expressed the tocopherol levels as the
ratio of tocopherol:(total cholesterol+triglycerides) as
proposed by Turnham et al [26]. When the concentration
of cholesterol and triglycerides was adjusted for, the
changes in plasma α-tocopherol did not reach statistical
significance. Usually, the concentrations of tocopherols
are expressed as tocopherol:total cholesterol or  tocophe-
rol:(total cholesterol+triglycerides), but since γ-tocopherol
only correlated to triglycerides we also calculated the γ-
tocopherol:triglycerides ratio. When γ-tocopherol was
presented in relation to triglycerides this concentration
was also unchanged.
Nevertheless, although the reported intake of vitamin E
was higher in the MD group, the lipid adjusted plasma
levels did not increase. One reason for this could be a
decreased intake of fat, since the bio-availability of vita-
min E is affected by the presence of fat. For the same rea-
son the fat intake could also have affected the levels of β-
carotene. According to the diet history interviews the MD
group had a significantly lower intake of total fat com-
pared to the CD group (p = 0.005) (data not presented).
However, the relation between the intake of fat and vita-
min E in each meal must be investigated to clarify this.
The intake of fat and biochemical markers of fat intake
will be presented elsewhere.
The levels of tocopherols in the MD group may also have
been affected by the increased intake of fish or other foods
rich in polyunsaturated fatty acids (PUFA). These fatty
acids are easily oxidized and may therefore increase the
expenditure of vitamin E. Tulleken et al [27], compared
two groups of RA patients receiving either supplementa-
tion with fish oil (rich in ω-3 PUFA) plus 12.9 mg α-toco-
pherol or coconut oil plus 10.3 mg of α-tocopherol daily.
Although the coconut oil-treated group received slightly
less α-tocopherol, by the end of the study measures of
vitamin E status were significantly higher in this group
compared to the fish oil-treated group.
The influence of antioxidant-rich foods on the plasma
concentration of antioxidants has been investigated in
healthy subjects. Zino et al [28], showed that an increased
intake of fruit and vegetables resulted in a raised plasma
concentration of vitamin C, α-carotene and β-carotene.
Interestingly, these changes were seen within the first two
weeks of intervention, indicating that the plasma antioxi-
dants in question respond quite fast to changes in dietary
intake of antioxidants. In contrast, the levels of tocophe-
rols may be more difficult to elevate by means of increas-
ing the intake of vitamin E-rich foods [29].
In healthy individuals the plasma levels of antioxidants
may be affected by many factors other than the nutrient
intake, such as the degree of absorption, intake of other
nutrients, homeostatic regulation etc. How the plasma
antioxidants of RA patients are influenced by intervention
with an antioxidant-rich diet has, to our knowledge, not
been studied before. A possible explanation for the lack of
correlation between dietary intake and plasma antioxi-
dants, in the present investigation, is that the plasma lev-
els of nutrients are mainly influenced by the
inflammatory process, and to a lesser extent by the dietary
intake. Several authors have reported depressed antioxi-
dant levels in the plasma or serum of RA patients [30–36].
In addition, Honkanen et al [37] showed that in 50 RA
patients, six parameters of disease activity explained 66%
of the variation in serum zinc. They also reported that the
low level of serum selenium found in RA patients was
associated with joint score. We found that plasma retinol,
ascorbic acid and uric acid were inversely related to indi-
ces of disease activity. In contrast to our results, in one
study the level of serum vitamin A was shown not to be
associated with blood parameters of inflammation or the
joint score [35]. Only disease activity assessed by the phy-
sician was related to the level of vitamin A. However, in
the NHANES III study, serum retinol was found to be
lower in subjects with elevated CRP concentrations [38].
Others have suggested that the low plasma/serum levels of
antioxidants seen in RA patients are a result of an inade-
quate dietary intake. A number of authors have docu-
mented poor intakes of antioxidants among RA patients
[34,39–41], but all studies are not in agreement [42]. Fur-
thermore, in all of the studies where the nutrient intake
was reported to be deficient, the energy intake was also
rather low. Thus, it is not unlikely that the subjects have
underreported their dietary intake. In the present study we
have primarily related the dietary intake to the AR accord-
ing to the NNR. When under-reporters were excluded
(one MD and two CD subjects) all the subjects reached
the AR for vitamin A and C. However, with regard to the
selenium intake, 27% (4/15) of the CD subjects did not
reach the AR for selenium. For vitamin E there is no spec-
ified AR, but in comparison with the recommended intake
(RI) all of the MD subjects and 60% (9/15) of the CD sub-
jects (excluding under-reporters) reached the RI, which for
most people is considerably higher than the requirement.
Hence, the result of this study does not point towards an
inadequate nutrient intake, perhaps with the exception of
selenium. However, our subjects had volunteered to par-
ticipate in a dietary intervention study and may not have
been representative for Swedish RA patients in general.
For instance, they might have had a greater interest inNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/5
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nutrition, and perhaps their dietary intake was, for this
reason, better than the intake of other RA patients.
Since antioxidant-rich foods, such as fruit and vegetables,
are in general regarded as healthy, it is possible that the
subjects have over-reported their intake of these food
items and consequently the nutrient intake would be
overestimated as well. If this was the case it could explain
the lack of correlation between nutrient intake and the
plasma levels of the corresponding nutrient, at least if, for
instance, subjects with a low nutrient intake over-report to
a greater extent.
Even if the reported intake of food items and nutrients
was correct, it may not have been sufficient to substan-
tially raise the plasma levels. In the study on healthy sub-
jects by Zino et al [28], an average extra intake of 700 g of
fruit and vegetables per day resulted in raised levels of
plasma antioxidants (vitamin C, α- and β-carotene).
Regarding vitamin E, McGavin et al showed that an
increased intake of vitamin E from, on average, 10 mg/day
to 22 mg/day only resulted in a small increase in plasma
α-tocopherol in healthy subjects [29]. For patients with
RA the required amount could be even higher due to the
impact of the disease.
In the present study, we have mainly focused on well-
known antioxidant nutrients. However, fruit, vegetables,
olive oil and tea also contain phytochemicals, such as
phenolic compounds, which in recent years have attracted
increased interest [2,3,13]. Apart from functioning as anti-
oxidants these compounds have been attributed anti-
inflammatory, antibiotic, and anti-carcinogenic proper-
ties [43]. In a recent study by Halvorsen et al, the total
antioxidant capacity of dietary plants was measured by the
FRAP assay [44]. They found that the antioxidants vitamin
C, α-tochopherol, α-carotene, β-carotene, lutein, zeaxan-
thin and lycopene only contributed to <25% of the FRAP
values of most dietary plants. Their results suggest that
other antioxidants may be of considerable importance for
the total antioxidative capacity. However, at this point
knowledge about the bio-availability and the in vivo activ-
ity of the different phenolic compounds is still
insufficient.
Uric acid
Uric acid is an end product of purine metabolism, which
also serves as a water soluble antioxidant and is present in
high concentrations in plasma. Situnayake et al [36] inves-
tigated the combined chain breaking antioxidant ability
of human serum by means of the Total (Peroxyl) Radical-
trapping Antioxidant Parameter (TRAP) assay. They found
that serum urate was the most important determinant of
TRAP in RA patients. In contrast, in the healthy control
group vitamin E explained most of the variance in TRAP
[36]. However, others have reported that urate also con-
tributed 35–60% to TRAP in healthy subjects [45]. It is not
likely that a shift to a Mediterranean-type diet would lead
to an increase in ingested nucleic acids, nor to increased
hydrolysis of endogenous nucleic acids and thereby
increase the plasma level of uric acid. However, since uric
acid contributes to the total antioxidant capacity we
decided to investigate the uric acid level as well. There was
a tendency to increased levels of uric acid in the MD group
at the start of the study, however by week 12 there was no
significant difference compared to baseline. The inverse
correlation between the thrombocyte count and uric acid
indicates that the level of uric acid is associated with the
degree of inflammation.
Malondialdehyde
In rheumatoid joints activated macrophages and neu-
trophils release several kinds of oxidants, which in high
concentrations lead to oxidative stress causing damage to
lipids, proteins, carbohydrates and DNA. Important tar-
gets for oxidants are the unsaturated fatty acids in cell
membranes. MDA is a product of lipid peroxidation and
thereby functions as a marker of oxidative stress. The level
of MDA in plasma or serum has been reported to be
higher in RA patients than in control subjects [46–49].
Earlier studies have also shown that the level of MDA is
related to RA disease activity. In one study Taysi et al [49],
found that serum MDA correlated positively with disease
activity score, and Deaney et al [50], have reported a cor-
relation between ESR and MDA plus another lipid
peroxidation product, 4-hydroxynonenal. In the present
study, where most patients had low to moderate disease
activity, no correlation between urine MDA and disease
activity variables were found. On the other hand, γ-toco-
pherol was inversely correlated to MDA at baseline. At a
group level, no significant changes in MDA or adjusted
MDA were seen from baseline to the end of the study,
indicating that lipid peroxidation was not significantly
affected by the intervention.
Conclusions
In conclusion, the intake frequencies of antioxidant rich
food items were increased in the MD group, and this
group also had a significantly higher intake of vitamin E
and selenium compared to the CD group. Despite the
reported increase in consumption frequency of antioxi-
dant-rich foods, the plasma levels of carotenoids, vitamin
C, lipid adjusted tocopherols, uric acid and MDA were
unchanged by the end of the study. The plasma levels of
retinol, vitamin C and uric acid were, however, correlated
to indices of disease activity.
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